Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +2.50% sank 0.12% to $165.22 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.46% falling 0.16% to 4,473.75 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.29% falling 0.18% to 34,751.32. Johnson & Johnson closed $14.70 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.24% rose 0.43% to $373.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.76% fell 1.15% to $71.97, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.42% fell 0.67% to $44.47. Trading volume (5.6 M) eclipsed its 50-day average volume of 5.6 M.